公司概述
Molina Healthcare, Inc. operates as a provider of managed healthcare services specifically targeting low-income families and individuals, serving populations enrolled in Medicaid and Medicare programs as well as participants in state insurance marketplaces across the United States. The company functions within the broader Healthcare sector and the more specific Healthcare Plans industry, a classification that signifies its role in administering and delivering health benefits rather than manufacturing pharmaceutical products or medical devices. Molina Healthcare, Inc. holds a market capitalization of $7.56B and reported total revenue of $43.56B for the trailing twelve months, while employing a workforce of 19,000 individuals to execute its operations. These valuation and revenue figures indicate that the entity represents a significant capitalization within its niche, possessing substantial annual revenue generation capabilities that support its extensive employee base and complex service delivery model across multiple regulatory environments.
财务健康
Molina Healthcare, Inc. generated $43.56B in revenue over the trailing twelve months, with net income reaching $472.00M and EBITDA standing at $902.00M, revealing a cost structure where operating expenses consume a significant portion of top-line growth, as evidenced by the gap between revenue and net income. The company reported a free cash flow of $-100,000,000, indicating a period of net cash outflow that suggests limited immediate financial flexibility for capital expenditures or dividend payments without external financing. Margin analysis shows a gross margin of 9.4%, an operating margin of -1.5%, and a profit margin of 1.1%, illustrating that while gross revenue retention is moderate, operating leverage has yet to generate positive operating income, though the final profit margin remains positive due to non-operating factors or tax effects. The balance sheet displays $8.26B in cash against $4.05B in debt, resulting in a debt-to-equity ratio of 99.44%, which points to a highly leveraged capital structure where debt obligations nearly equal shareholder equity. Despite the leverage, the current ratio stands at 1.69, suggesting that the company maintains adequate short-term liquidity to cover its current liabilities with current assets. Return on Equity is 11.0% and Return on Assets is 3.1%, metrics that reveal management's effectiveness in generating returns relative to shareholders' capital and the total asset base, respectively, with the higher ROE indicating efficient use of equity financing.
估值评估
The trailing P/E ratio is 16.26, while the forward P/E is projected at 16.76, implying that the market expects earnings growth to be modest or slightly slower than the current run rate, as the forward multiple is marginally higher than the trailing multiple. The price-to-book ratio stands at 1.82, indicating that the market values the company at a premium of 82% over its book value, reflecting expectations of future growth or brand value beyond the tangible assets recorded on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 0.17 and an EV/EBITDA of 3.61, suggesting that the stock is priced at a fraction of its sales, which often indicates deep value or specific industry-wide pricing pressures in the healthcare plans sector. The stock has traded between a 52-week low of $121.06 and a 52-week high of $358.89, meaning the current price sits significantly below the annual peak, specifically trading well under the 52-week high which reflects a substantial retracement from recent highs. The beta value is 0.55, indicating that the stock's price volatility is approximately 45% lower than the broader market, suggesting a defensive characteristic that decouples the stock's movements from general market swings during periods of volatility.
Growth & Income
Molina Healthcare, Inc. reported a revenue growth rate of 7.1% year-over-year, while earnings growth is listed as N/A, implying that the absence of reported earnings growth data prevents a direct comparison of earnings expansion relative to revenue expansion at this specific reporting period. As a non-dividend payer, the company maintains a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm retains all of its earnings rather than distributing them to shareholders, a strategy typical for companies reinvesting capital into operational growth or debt reduction. The overall growth and income profile is characterized by double-digit revenue expansion in a regulated environment without reliance on dividend income, positioning the company for potential future capital appreciation rather than current yield generation. This financial structure emphasizes capital retention and operational scaling within the Medicaid and Medicare segments rather than shareholder distributions.